Safe Muscle Relaxants During Breastfeeding
All neuromuscular blocking agents (suxamethonium, rocuronium, vecuronium, atracurium) are safe and compatible with breastfeeding, with no interruption of nursing required once the mother has recovered from anesthesia. 1, 2
Neuromuscular Blocking Agents (Safest Option)
Non-Depolarizing Agents
- Rocuronium, vecuronium, and atracurium are quaternary ammonium compounds with poor lipid solubility and poor oral bioavailability, making them unable to transfer into breast milk in significant amounts 1
- These agents are ionized at physiological pH, which prevents meaningful milk excretion 1
- Breastfeeding may resume immediately once the mother has recovered sufficiently from the neuromuscular block, with no waiting period required 1, 2
Depolarizing Agents
- Suxamethonium is unlikely to be present in breast milk in significant amounts due to ionization at physiological pH, poor oral absorption, and rapid elimination from maternal circulation 1
- Breastfeeding may be resumed once the woman has recovered from neuromuscular block 1
Reversal Agents (Also Safe)
- Neostigmine is a quaternary ammonium compound with a 15-30 minute half-life, and the amount transferred to breast milk is too small to be harmful 1
- Sugammadex is acceptable to use during breastfeeding because it is a large, highly polar molecule with very low milk levels and unlikely oral absorption by the infant 1, 2
- After sugammadex administration, patients taking oral hormonal contraceptives must follow "missed pill rules" 1
Oral Muscle Relaxants (Use with Extreme Caution)
Cyclobenzaprine
- Cyclobenzaprine shows low concentrations in human milk with a calculated relative infant dose of 0.5%, but due to its sedative properties, regular clinical assessment of the infant is recommended 3
- This agent should only be used when benefits clearly outweigh risks, given limited safety data 3
Critical Safety Considerations
Infant Monitoring Requirements
- Mothers taking any sedating muscle relaxant must never co-sleep with their infant, as natural maternal responsiveness may be inhibited 2, 4
- Extra caution is required for infants less than 6 weeks of age due to immature hepatic and renal function 2, 5
- Preterm infants have the highest medication sensitivity and require heightened vigilance 2, 5
- Monitor all infants for unusual drowsiness, poor feeding, or decreased responsiveness when mothers use any sedating medication 2
Alternative Pain Management for Musculoskeletal Pain
First-Line Approach
- Multimodal analgesia with non-opioid drugs should be the first-line approach for musculoskeletal pain in lactating mothers 2, 5
- Paracetamol and ibuprofen are the safest first-line options, compatible with immediate breastfeeding without any waiting period 2, 5, 4
- Other NSAIDs including diclofenac, naproxen, celecoxib, ketorolac, and parecoxib are also safe alternatives 2, 4
When Opioids Are Required
- If opioid analgesia is required for severe pain, morphine is the preferred choice at the lowest effective dose for the shortest duration 2, 5, 4
- Single doses of morphine pose minimal risk, but repeated doses require infant monitoring for drowsiness and poor feeding 5, 4
Common Pitfalls to Avoid
- Do not use aspirin in analgesic doses during breastfeeding (low-dose aspirin ≤100 mg/day for antiplatelet action is acceptable if strongly indicated) 5, 4
- There is no need to "pump and dump" with neuromuscular blocking agents, paracetamol, or ibuprofen 5
- Do not delay breastfeeding after neuromuscular blocking agents once the mother has recovered from anesthesia 1, 2